Close
Nordic 9Nordic 9

Ava Investors (investor - Venture Capital)

United States ava-investors.com
See something wrong or missing? Let us know
Average round investment:1.1B USD
Average number per year:2.0
Distribution: 2022 (2)
Portfolio companies: Sweden NorthvoltSwitzerland Rejuveron Life Sciences
Mostly invests in: Sweden Sweden (1) Energy (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ava Investors

Name Criteria
United Kingdom The Oxford Foundry
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany JIH family office
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Finland DevCo Partners
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Mertiva
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Switzerland SNGLR Capital
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Active last 12 months: Yes
United States Chris Mayle
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Marc Gare
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Frank Cid
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Canada Sebastian De La Rosa
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
France Keensight Capital
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Top